Status:
UNKNOWN
Study for Patients With Non Small Cell Lung Cancer (NSCLC)
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Bristol-Myers Squibb
Pierre Fabre Pharma GmbH
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a randomized study to assess the efficacy and safety of chemotherapy with platin compared to chemotherapy without platin.
Detailed Description
Randomized Phase II design, multicenter study, to assess the efficacy and safety of combined chemotherapy with Paclitaxel and Carboplatin versus a platinum free chemotherapy with Paclitaxel and Vinore...
Eligibility Criteria
Inclusion
- Chemotherapy naive patients with histologically confirmed NSCLC stage III and IV
Exclusion
- New York Heart Association (NYHA) III or IV
- Brain metastases
- Neurotoxicity Grade 2 or greater
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00168883
Start Date
October 1 2002
End Date
December 1 2006
Last Update
November 1 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematology & Oncology Charité CBF Berlin
Berlin, State of Berlin, Germany, 12203